Story perspectives

Study Reveals mRNA Codon Selection's Role in Disease Therapy

11/9/2025

Summary

Story summary

Researchers from the Whitehead Institute and MIT show that alternative start codon selection in mRNAs creates distinct protein isoforms with different cellular destinations, affecting mitochondrial function and rare diseases.
The mechanism enables selective impairment of one isoform while preserving another, suggesting novel opportunities for disease modulation.
The study urges better integration of translation-level annotations in variant databases to improve diagnosis, understanding genotype-phenotype relationships, and prospects for isoform-selective therapies.

1 of 1

Story summary

Researchers from the Whitehead Institute and MIT show that alternative start codon selection in mRNAs creates distinct protein isoforms with different cellular destinations, affecting mitochondrial function and rare diseases.
The mechanism enables selective impairment of one isoform while preserving another, suggesting novel opportunities for disease modulation.
The study urges better integration of translation-level annotations in variant databases to improve diagnosis, understanding genotype-phenotype relationships, and prospects for isoform-selective therapies.